Literature DB >> 31062188

The Impact of the Depth of Venous Invasion on Survival Following Pancreatoduodenectomy for Pancreatic Cancer: a Meta-analysis of Available Evidence.

Chathura B B Ratnayake1,2, Nehal Shah3, Benjamin Loveday4, John A Windsor1,2, Sanjay Pandanaboyana5.   

Abstract

PURPOSE: The prognostic significance of portal/superior mesenteric vein (PV/SMV) invasion at the time of pancreatoduodenectomy (PD) for pancreatic adenocarcinoma (PDAC) is contentious. The aim of this meta-analysis was to compare the survival outcomes in patients with histologically proven adventitial (superficial) versus media/intimal (deep) PV/SMV invasion at the time of PD for PDAC.
METHODS: A systematic search of the PubMed, MEDLINE and SCOPUS databases were performed in accordance with PRISMA guidelines. All articles reporting outcomes specific to the depth of PDAC invasion into the PV/SMV wall were included. The primary outcome measure was overall survival.
RESULTS: Six studies including 310 patients who underwent pancreatic resection with PV/SMV resection for PDAC were included in this meta-analysis. There was no difference in overall survival comparing superficial vs deep invasion at 12 months (64% vs 58% respectively, risk difference, - 0.09; CI, - 0.21-0.04; P = 0.183), 36 months (22% vs 18% respectively, risk difference, - 0.05; CI, - 0.16-0.19; P = 0.857) and mean overall survival (42.8 months vs 25.7 months respectively, standard mean difference, - 0.27; CI, - 0.58, 0.03; P = 0.078). Although larger tumours were seen in those with confirmed deep vein wall invasion (P < 0.001), no difference was observed between the superficial and deep invasion groups with regard to age (P = 0.298), R1 resection (P = 0.896), nodal metastatic disease (P = 0.120) and perineural invasion (P = 0.609).
CONCLUSIONS: This meta-analysis suggests that the depth of PV/SMV wall invasion by PDAC may not impact survival after PD. However, given the limited sample size, further research is warranted with homogenous cohorts and longer follow-up.

Entities:  

Keywords:  Pancreatic cancer; Pancreatoduodenectomy; Porto-mesenteric vein; Vein wall invasion

Year:  2020        PMID: 31062188     DOI: 10.1007/s12029-019-00248-3

Source DB:  PubMed          Journal:  J Gastrointest Cancer


  3 in total

1.  Pathology of Treated Pancreatic Ductal Adenocarcinoma and Its Clinical Implications.

Authors:  Teddy Sutardji Nagaria; Hua Wang; Deyali Chatterjee; Huamin Wang
Journal:  Arch Pathol Lab Med       Date:  2020-07-01       Impact factor: 5.686

2.  Impact of prior biliary stenting on diagnostic performance of endoscopic ultrasound for mesenteric vascular staging in patients with head of pancreas and periampullary malignancy.

Authors:  Kofi W Oppong; Manu K Nayar; Noor L H Bekkali; Pardeep Maheshwari; Beate Haugk; Antony Darne; Derek M Manas; Jeremy J French; Steven White; Gourab Sen; Sanjay Pandanaboyana; Richard M Charnley; John S Leeds
Journal:  BMJ Open Gastroenterol       Date:  2022-03

3.  Possible involvement of HSP70 in pancreatic cancer cell proliferation after heat exposure and impact on RFA postoperative patient prognosis.

Authors:  Hui-Bin Song
Journal:  Biochem Biophys Rep       Date:  2019-10-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.